![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 16/30 | (2006.01) |
A61K2039/505 | (2013.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/30 | (2013.01) | ||
C07K 16/40 | (2006.01) | ||
C07K2317/21 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K2317/77 | (2013.01) | ||
A61K 47/68 | (2017.01) | ||
C07K2317/92 | (2013.01) | ||
C07K2317/34 | (2013.01) | ||
A61P 35/00 | (2018.01) | ||
C07K 16/40 | (2013.01) | ||
A61K 47/6871 | (2017.08) | ||
A61K 47/6803 | (2017.08) |
(11) | Patento numeris | 3520816 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19153014.6 |
Europos patento paraiškos padavimo data | 2010-10-22 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-31 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
25447409 P | 2009-10-23 | US |
(72) |
NAM, Samuel, S. , US
GREENFIELD, Edward, A. , US
BABCOOK, John , CA
O'KEEFE, Theresa , US
QIN, Shixin , US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
Amgen British Columbia , 7990 Enterprise Street, Burnaby, BC V5A 1V7, CA |
(54) | ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |
ANTI-GCC ANTIBODY MOLECULES AND RELATED COMPOSITIONS AND METHODS |